Literature DB >> 34116538

Effectiveness of a Tele-Ophthalmology Vision Center in Treating Corneal Disorders and Its Associated Economic Benefits.

Sangoi Komal1, Naveen Radhakrishnan1, Ashok Vardhan S2, N Venkatesh Prajna1.   

Abstract

PURPOSE: The aim of this study was to study the clinical and economic impact of a teleophthalmology-based vision center (VC) in the management of corneal diseases in rural south India.
METHODS: Data of patients with corneal disorders who visited the VC in the year 2019 were analyzed for the total number of outpatient visits, the proportion of corneal cases that were treated at the VC, those referred to the base hospital (BH), and the costs of treatment.
RESULTS: In 2019, 1131 (10%) of 10,850 patients who visited the VC were diagnosed with corneal disorders. Of these, 950 (84%) patients were treated at the VC itself and did not require to be referred. The remaining 181 (16%) were referred to the BH. Of these 1131 patients, 836 (74%) patients presented with a painful acute corneal disorder. The most common painful acute corneal disorders included corneal foreign body (376, 33%), epithelial abrasions (205, 18%), and infectious keratitis (124, 11%). A patient can save approximately a minimum of INR 1200 (USD 16) by attending the VC rather than the BH. In 2019, by treating 950 patients, the VC saved approximately INR 114,0000 (USD 15,200) for the community. A similar calculation extrapolated to a 10-year period (2009-2019) revealed that by providing care for these corneal disorders at the community level, the VC saved approximately INR 705,8400 (USD 94,112) for the community.
CONCLUSIONS: VC reduces the barriers to care by increasing the accessibility and affordability of treatment for patients with corneal disorders, resulting in a significant cost saving to the community.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34116538     DOI: 10.1097/ICO.0000000000002784

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  5 in total

1.  Impact of Implementing Teleophthalmology Referral Guidelines Using the eyeSmart EMR App in 63,703 Patients from India.

Authors:  Anthony Vipin Das; Rohit C Khanna; Niranjan Kumar; Padmaja Kumari Rani
Journal:  Int J Telemed Appl       Date:  2022-01-27

2.  The use of teleconsultation and technology by the Aravind Eye Care System, India.

Authors:  R Kim; Chitaranjan Mishra; Sagnik Sen
Journal:  Community Eye Health       Date:  2022-06-07

3.  Early treatment of corneal abrasions and ulcers-estimating clinical and economic outcomes.

Authors:  Varsha M Rathi; Praveen Thokala; Sheila MacNeil; Rohit C Khanna; Peter N Monk; Prashant Garg
Journal:  Lancet Reg Health Southeast Asia       Date:  2022-09

4.  Comparative study on costs incurred for treatment of patients with bacterial and fungal keratitis - A retrospective analysis.

Authors:  Naveen Radhakrishnan; Neha Pathak; Krishnan Raja Subramanian; Daisy Rani Das; Reagan Ningombam; Isha Khaitan; Neha Gandhi; Ramesh Rahul; N Venkatesh Prajna
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

5.  Commentary: Tackling the "silent epidemic".

Authors:  Bhaskar Srinivasan; Geetha Iyer; Shwetha Agarwal
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.